STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 102 filers reported holding STOKE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $262,561 | -92.8% | 24,700 | -93.7% | 0.00% | -100.0% |
| Q4 2022 | $3,639,500 | +45.8% | 394,312 | +102.8% | 0.00% | 0.0% |
| Q3 2022 | $2,496,250 | -2.8% | 194,412 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,568,183 | -16.2% | 194,412 | +33.5% | 0.00% | 0.0% |
| Q1 2022 | $3,064,880 | +166.5% | 145,600 | +222.1% | 0.00% | – |
| Q3 2021 | $1,150,000 | +114.2% | 45,200 | +80.8% | 0.00% | – |
| Q3 2019 | $537,000 | -26.3% | 25,000 | 0.0% | 0.00% | – |
| Q2 2019 | $729,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $475,340,000 | 79.82% |
| RTW INVESTMENTS, LP | 3,544,248 | $100,373,000 | 3.79% |
| Cormorant Asset Management, LP | 1,788,643 | $50,654,000 | 2.02% |
| RA Capital Management | 1,119,963 | $31,717,000 | 0.96% |
| Redmile Group, LLC | 1,020,778 | $28,908,000 | 0.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 256,380 | $7,261,000 | 0.60% |
| GILDER GAGNON HOWE & CO LLC | 1,826,890 | $51,738,000 | 0.54% |
| Perceptive Advisors | 671,978 | $19,030,000 | 0.38% |
| Casdin Capital, LLC | 130,000 | $3,682,000 | 0.34% |
| Granite Point Capital Management, L.P. | 13,200 | $374,000 | 0.06% |